Pancreatic Cancer Research

ResearcherJiangsu UniversityNo recent work listed

Xu‐Qing Wang

Matched on ORCID iD 0009-0001-6346-3171; OpenAlex author ID A5103167135. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 3 papers · 2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper

Papers 10

  1. Corrigendum to "Krüppel-like factor 9 suppressed tumorigenicity of the pancreatic ductal adenocarcinoma by negatively regulating frizzled-5" [Biochem. Biophys.… Co-author DOI 10.1016/j.bbrc.2019.01.086↗
  2. Krüppel-like factor 9 suppressed tumorigenicity of the pancreatic ductal adenocarcinoma by negatively regulating frizzled-5. Co-author DOI 10.1016/j.bbrc.2018.03.229↗
  3. KLF9 Is a Prognostic Indicator in Human Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.11756↗
  4. Secreted protein acidic and rich in cysteine enhances the chemosensitivity of pancreatic cancer cells to gemcitabine. Co-author DOI 10.1007/s13277-015-4044-4↗
  5. FOXC2 is up-regulated in pancreatic ductal adenocarcinoma and promotes the growth and migration of cancer cells. Co-author DOI 10.1007/s13277-015-4607-4↗
  6. Up-regulation of UHRF1 by oncogenic Ras promoted the growth, migration, and metastasis of pancreatic cancer cells. Co-author DOI 10.1007/s11010-014-2279-9↗
  7. Cyclooxygenase 2 promoted the tumorigenecity of pancreatic cancer cells. Last author DOI 10.1007/s13277-013-1301-2↗
  8. Secreted protein acidic and rich in cysteine inhibits the growth of human pancreatic cancer cells with G1 arrest induction. Last author DOI 10.1007/s13277-014-2315-0↗
  9. [Mechanism of SPARC-enhanced chemosensitivity of pancreatic cancer cells to gemcitabine]. Co-author PMID 25030587↗
  10. CCN1 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway in pancreatic cancer. Co-author DOI 10.1007/s13277-012-0434-z↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhengfa Mao · 9 shared papers, 2012–2019 · strength 0.59
  2. Jianxin Zhang · 6 shared papers, 2014–2019 · strength 0.44
  3. Xin Fan · 6 shared papers, 2012–2018 · strength 0.36
  4. Peiyu Ji · 2 shared papers, 2018–2019 · strength 0.21
  5. Sheng-Chun Dang · 3 shared papers, 2015–2016 · strength 0.18
  6. Lei Cui · 3 shared papers, 2014–2016 · strength 0.16
  7. Jianxin Zhang · 3 shared papers, 2012–2016 · strength 0.15
  8. Lei Cui · 3 shared papers, 2012–2016 · strength 0.15
  9. Jixiang Chen · 2 shared papers, 2015–2016 · strength 0.12
  10. Yong Zhang · 1 shared paper, 2017 · strength 0.08
  11. Christoph W. Michalski · 1 shared paper, 2017 · strength 0.08
  12. Wenjun Li · 1 shared paper, 2014 · strength 0.06
  13. Ying Wang · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.